A Retrospective Study of Visual Outcomes When Using a Cloud-Based Surgical Planning Platform and the Barrett Universal II Formula.

Clinical ophthalmology (Auckland, N.Z.) Pub Date : 2024-09-17 eCollection Date: 2024-01-01 DOI:10.2147/OPTH.S481797

Eric Jennings, Brad Hall

{"title":"A Retrospective Study of Visual Outcomes When Using a Cloud-Based Surgical Planning Platform and the Barrett Universal II Formula.","authors":"Eric Jennings, Brad Hall","doi":"10.2147/OPTH.S481797","DOIUrl":null,"url":null,"abstract":"Purpose: To evaluate the efficacy of a cloud-based surgical planning platform with regards to refractive target accuracy.Methods: This was a retrospective chart review of consecutive cases from January 2022 through December 2023. Surgical planning was performed using the SMARTCataract platform, eyes were implanted with Clareon monofocal IOLs, and power calculations were done using the Barrett Universal II formula. Data were collected for the percentage of eyes within ±0.5 D of target refraction, mean absolute error (MAE), and postoperative visual acuity.Results: A total of 148 eyes were identified that met the inclusion/exclusion criteria. The percentage of eyes within ±0.5 D of the planned target was 94%. The MAE was 0.25 ± 0.17 D. In addition, 57%, 93%, 98%, and 100% of eyes had MAE ≤ 0.25 D, ≤ 0.5 D, ≤ 0.75 D, and ≤ 1.0 D, respectively.Conclusion: The results of this study suggest high refractive accuracy when using the SMARTCataract planning platform with the Barrett Universal II formula and excellent distance visual acuity.","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11416102/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical ophthalmology (Auckland, N.Z.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OPTH.S481797","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To evaluate the efficacy of a cloud-based surgical planning platform with regards to refractive target accuracy.

Methods: This was a retrospective chart review of consecutive cases from January 2022 through December 2023. Surgical planning was performed using the SMARTCataract platform, eyes were implanted with Clareon monofocal IOLs, and power calculations were done using the Barrett Universal II formula. Data were collected for the percentage of eyes within ±0.5 D of target refraction, mean absolute error (MAE), and postoperative visual acuity.

Results: A total of 148 eyes were identified that met the inclusion/exclusion criteria. The percentage of eyes within ±0.5 D of the planned target was 94%. The MAE was 0.25 ± 0.17 D. In addition, 57%, 93%, 98%, and 100% of eyes had MAE ≤ 0.25 D, ≤ 0.5 D, ≤ 0.75 D, and ≤ 1.0 D, respectively.

Conclusion: The results of this study suggest high refractive accuracy when using the SMARTCataract planning platform with the Barrett Universal II formula and excellent distance visual acuity.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

使用基于云的手术规划平台和巴雷特通用 II 公式时视觉效果的回顾性研究。

目的：评估基于云计算的手术规划平台在屈光目标准确性方面的功效：这是对 2022 年 1 月至 2023 年 12 月连续病例的回顾性病历审查。使用SMARTCataract平台进行手术规划，为双眼植入Clareon单焦点人工晶体，并使用Barrett Universal II公式进行功率计算。收集的数据包括目标屈光度在±0.5 D以内的眼睛百分比、平均绝对误差（MAE）和术后视力：结果：共有 148 只眼睛符合纳入/排除标准。目标屈光度在±0.5 D以内的眼占 94%。此外，分别有 57%、93%、98% 和 100% 的眼睛 MAE ≤ 0.25 D、≤ 0.5 D、≤ 0.75 D 和≤ 1.0 D：本研究结果表明，使用 SMARTCataract 计划平台和 Barrett Universal II 公式时，屈光准确度高，远视力极佳。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical ophthalmology (Auckland, N.Z.)

CiteScore

4.10

自引率

0.00%

发文量